Medical director

FzioMed, Inc. to Showcase its Women's Health Adhesion Barrier Products at Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) Congress

Retrieved on: 
Tuesday, April 16, 2024
Adhesion, Curettage, Pain, Ovary, Congress, Refrigeration, Safety, Pregnancy, Risk, Tissue, Infertility, Federico, Marketing, Doctor of Philosophy, Obstetrics, Gynaecology, Hysteroscopy, Teaching hospital, Patient satisfaction, SAN, Medical director, The Company, Gel

The Company will showcase its innovative Oxiplex® adhesion barrier gel product portfolio designed to reduce the formation of post-surgical adhesions following hysteroscopic and laparoscopic surgery.

Key Points: 
  • The Company will showcase its innovative Oxiplex® adhesion barrier gel product portfolio designed to reduce the formation of post-surgical adhesions following hysteroscopic and laparoscopic surgery.
  • Based on a patented formulation and more than 20 years of use, these barrier products provide a temporary, mechanical separation of tissues during the normal healing process, reducing adhesion formation.
  • "Formulated specifically for intrauterine procedures, our Oxiplex/IU Adhesion Barrier Gel works in concert with the natural healing process to reduce adhesion formation.
  • The Oxiplex portfolio of adhesion barrier products has been available since 2002 and have been used in nearly 1 million procedures worldwide.

VIO Med Spa Announces Appointment of Dr. Alan Durkin as Chief Medical Officer

Retrieved on: 
Tuesday, April 16, 2024
Elective surgery, American Board of Surgery, Patient safety, VIO, Patient, Health, Plastic surgery, Medical director, Medical device

CLEVELAND, April 16, 2024 /PRNewswire/ -- VIO Med Spa, a pioneering force in the franchise medical spa industry, is thrilled to announce the appointment of Dr. Alan Durkin, M.D., as its new Chief Medical Officer.

Key Points: 
  • CLEVELAND, April 16, 2024 /PRNewswire/ -- VIO Med Spa, a pioneering force in the franchise medical spa industry, is thrilled to announce the appointment of Dr. Alan Durkin, M.D., as its new Chief Medical Officer.
  • VIO Med Spa is thrilled to announce the appointment of Dr. Alan Durkin, M.D., as its new Chief Medical Officer.
  • Dr. Durkin, a distinguished dual Board-Certified Plastic & Reconstructive Surgeon, brings to VIO Med Spa a remarkable portfolio of achievements and a wealth of experience.
  • "Dr. Durkin's appointment reaffirms our commitment to excellence and innovation," says Ryan Rose, CEO of VIO Med Spa.

Expanding Oncology Services: Introducing Gynecologic Oncologist Dr. Erin Blake and Medical Oncologist Dr. Martin Majer to Integrated Oncology Network and cCARE

Retrieved on: 
Thursday, April 11, 2024
Oncology, ION, Hope, Woman, Partnership, Research, Life, Patient, Master of Science, Oncology nursing, Health, Medical director

NASHVILLE, Tenn., April 11, 2024 /PRNewswire/ -- Integrated Oncology Network (ION), in partnership with California Cancer Associates for Research & Excellence (cCARE), is excited to welcome two esteemed oncologists, Erin Blake, MD and Martin Majer, MD, to our growing medical team, expanding our comprehensive cancer care services to serve our community better.

Key Points: 
  • Dr. Erin Blake, MD, MSc, a fellowship-trained and board-certified gynecologic oncologist, joins us with a commitment to advancing gynecologic cancer care and research.
  • With a strong academic background and extensive experience, Dr. Blake brings expertise in patient-focused strategies to empower individuals throughout their journey with gynecologic cancers.
  • "I'm proud to join cCARE and ION, where I can contribute to advancing gynecologic oncology care.
  • Dr. Erin Blake and Dr. Martin Majer are now accepting patients at cCARE.

Healthcare Revolution 2024: Largest Industry Event Moves to Drive Superior Results in Healthcare and Medical Tourism

Retrieved on: 
Thursday, April 11, 2024
Korea Tourism Organization, Medical tourism, Organizational culture, AI, Health, Partnership, BEACH, PALM, Asan Medical Center, JD, EST, Culture, Medical director, Growth, Moonshot, Pharmaceutical industry

Learn exciting strategies to get ahead in the ever-evolving medical tourism landscape and ways to optimize your corporate health systems that no one else will teach you.

Key Points: 
  • Learn exciting strategies to get ahead in the ever-evolving medical tourism landscape and ways to optimize your corporate health systems that no one else will teach you.
  • This year's event themed "Optimizing Costs, Elevating Programs, and Achieving Superior Results," again focuses on the three key Moonshots launched a few years ago – Costs, Culture, and Care.
  • "HREV 2024 is another exciting time to get insights into new solutions to solve pressing challenges in today's healthcare landscape.
  • Healthcare Revolution 2024 is in partnership with the Medical Tourism Association and is sponsored by the Korea Tourism Organization, South Korea's official corporation in charge of the country's tourism industry.

Healthcare Revolution 2024: Largest Industry Event Moves to Drive Superior Results in Healthcare and Medical Tourism

Retrieved on: 
Thursday, April 11, 2024
Korea Tourism Organization, Medical tourism, Organizational culture, AI, Health, Partnership, BEACH, PALM, Asan Medical Center, JD, EST, Culture, Medical director, Growth, Moonshot, Pharmaceutical industry

Learn exciting strategies to get ahead in the ever-evolving medical tourism landscape and ways to optimize your corporate health systems that no one else will teach you.

Key Points: 
  • Learn exciting strategies to get ahead in the ever-evolving medical tourism landscape and ways to optimize your corporate health systems that no one else will teach you.
  • This year's event themed "Optimizing Costs, Elevating Programs, and Achieving Superior Results," again focuses on the three key Moonshots launched a few years ago – Costs, Culture, and Care.
  • "HREV 2024 is another exciting time to get insights into new solutions to solve pressing challenges in today's healthcare landscape.
  • Healthcare Revolution 2024 is in partnership with the Medical Tourism Association and is sponsored by the Korea Tourism Organization, South Korea's official corporation in charge of the country's tourism industry.

ACMG Foundation for Genetic and Genomic Medicine Elects Four Highly Accomplished Medical Genetics Professionals to its Board of Directors

Retrieved on: 
Thursday, April 11, 2024
Education, Disorder, Rady Children's Hospital, Entrepreneurship, Doctor of Philosophy, Pathology, ACMG, Medical director, American Academy, Veterinarian, Myriad Genetics, FACMG, Drug, Genetic testing, Baylor College of Medicine, Distinguishing, International HapMap Project, New York University, Clinical Pediatrics, National academy, Hospital, Hispanic, Book, Health, American Medical Association, Research, Pediatrics (journal), Mental health, Master of Science, Genetic distance, Pediatrics, Women's health, School, Washington State University, Society, Cancer, Partnership, Genomics, American College, Policy, Genetic, Disability studies, Developmental Biology (journal), Friends, Patient, MED, MBA, Baylor University

The ACMG Foundation is a national nonprofit foundation dedicated to facilitating the integration of genetics and genomics into medical practice.

Key Points: 
  • The ACMG Foundation is a national nonprofit foundation dedicated to facilitating the integration of genetics and genomics into medical practice.
  • The board members are active participants, serving as advocates for the ACMG Foundation and for advancing its policies and programs.
  • ACMG Foundation President Nancy J. Mendelsohn, MD, FACMG said, "We are pleased to welcome these four new members to the ACMG Foundation Board of Directors.
  • "I am honored for the opportunity to serve the ACMG again through participation in the Foundation Board of Directors.

Hexiris Welcomes Dr. Paul Harasymowycz to Its Scientific Committee

Retrieved on: 
Tuesday, April 2, 2024
McGill University, Glaucoma, Health, Pressure, CUO, Disease, Associate, Risk, Patient, Knowledge, Research, MD, Slit lamp, Ophthalmology, Publication, Medical director, FDA, Glaucoma surgery, Medical device

DIEPPE, New Brunswick, April 02, 2024 (GLOBE NEWSWIRE) -- Hexiris Inc. (“Hexiris” or the “Company”), a medical device firm dedicated to advancing and simplifying Minimally Invasive Glaucoma Surgery (MIGS), is pleased to announce that Dr. Paul Harasymowycz, renowned ophthalmologist and recognized innovator in MIGS techniques, has joined Hexiris’s Scientific Committee.

Key Points: 
  • DIEPPE, New Brunswick, April 02, 2024 (GLOBE NEWSWIRE) -- Hexiris Inc. (“Hexiris” or the “Company”), a medical device firm dedicated to advancing and simplifying Minimally Invasive Glaucoma Surgery (MIGS), is pleased to announce that Dr. Paul Harasymowycz, renowned ophthalmologist and recognized innovator in MIGS techniques, has joined Hexiris’s Scientific Committee.
  • “We are proud that Dr. Harasymowycz has agreed to join our scientific committee,” said Dr. Nir Shoham-Hazon, Co-Founder and Co-CEO of Hexiris.
  • Over the past 20 years, Dr. Harasymowycz has distinguished himself through his extensive research and more than 90 publications in national and international scientific journals, and book chapters on glaucoma.
  • As a result, the Hexiris MIGS Solution is expected to generate considerable cost benefits for the health system.

SureGo Administrative Services, a Division of Trawick International, Expands Servicing Capabilities into Europe

Retrieved on: 
Tuesday, March 26, 2024
Insurance, Medical director, Organization, Growth, Management

FAIRHOPE, Ala. and BELGRADE, Serbia, March 26, 2024 (GLOBE NEWSWIRE) -- SureGo Administrative Services , a U.S.-based third-party administrator and division of Trawick International, today announced it has expanded its global footprint with the establishment of a representative office in Belgrade, Serbia.

Key Points: 
  • FAIRHOPE, Ala. and BELGRADE, Serbia, March 26, 2024 (GLOBE NEWSWIRE) -- SureGo Administrative Services , a U.S.-based third-party administrator and division of Trawick International, today announced it has expanded its global footprint with the establishment of a representative office in Belgrade, Serbia.
  • Formed as an independent third-party administrator, SureGo’s representative office will serve Trawick International as well as other insurance and related organizations worldwide.
  • This expansion underscores SureGo's commitment to its transformation and growth strategy, aiming to serve a wider array of business lines and customers across the globe.
  • The company is experiencing remarkable growth and participating in this phase of our evolution is exhilarating, both as a member of SureGo and within the larger Trawick family of companies.”

Tetricus Labs Partners with Silver Hill Hospital on Research to Advance Precision Psychiatry

Retrieved on: 
Tuesday, April 9, 2024
Data Management, Technology, Other Health, Health, Neurology, Mental Health, Research, Software, Artificial Intelligence, Hospitals, Science, Dow, Panic disorder, Psychiatry, Data science, Associate, Silver, Partnership, Patient, Tetricus, Bipolar disorder, Radiology, Neuroscience, Doctor of Philosophy, DSM-IV codes, Evercore, MD, Psychology, Silver Hill Hospital, Social anxiety disorder, Machine learning, Medical director, Yale University, Medicine, Nursing

Precision psychiatry startup Tetricus Labs has partnered with Silver Hill Hospital , one of the nation’s premier psychiatric hospitals, on a two-year feasibility study to assess how machine learning can significantly improve patient outcomes.

Key Points: 
  • Precision psychiatry startup Tetricus Labs has partnered with Silver Hill Hospital , one of the nation’s premier psychiatric hospitals, on a two-year feasibility study to assess how machine learning can significantly improve patient outcomes.
  • “We're patient-founded, patient-owned, and patient-run,” said Dow, CEO for Tetricus Labs.
  • Andrew J. Gerber, MD, PhD, President and Medical Director of Silver Hill Hospital, will join Tetricus Labs as a Medical Advisor to ensure Tetricus’ machine learning software is designed to fit within the busy workflow of hospital clinicians and staff, maximizing its accessibility for providers and potential impact on patient outcomes.
  • “This partnership represents our continued commitment to exploring innovative methods that can enhance our understanding of psychiatric disorders and improve patient outcomes."

Nucleai and GoPath Diagnostics Announce Strategic Collaboration to Provide Integrated AI-powered Digital Pathology Solutions for Clinical Research and Diagnostic Applications

Retrieved on: 
Monday, April 8, 2024
Other Health, Software, Research, Pharmaceutical, Oncology, Technology, Artificial Intelligence, Genetics, Health Technology, Science, Biotechnology, Health, College, GCP, LMS, Algorithm, Prostate cancer, Case management, Good clinical laboratory practice, Partnership, LIMS, CLEP, Biomarker, GCLP, AI, CAP, Good clinical practice, IBD, Medicine, Workflow, CLIA, Pathology, Inflammatory bowel disease, Medical director, Medical device

Nucleai , a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, today announced a strategic collaboration with GoPath Diagnostics , a leading full-service digital pathology and molecular diagnostics laboratory.

Key Points: 
  • Nucleai , a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, today announced a strategic collaboration with GoPath Diagnostics , a leading full-service digital pathology and molecular diagnostics laboratory.
  • This partnership unites Nucleai and GoPath's complementary skills to expedite the development of new AI-powered clinical research and diagnostics.
  • The integrated solutions will be deployed within a centralized environment that meets the standards of the College of American Pathologists (CAP), Clinical Laboratory Improvement Amendments (CLIA), Clinical Laboratory Evaluation Program (CLEP), Good Clinical Practice (GCP), and Good Clinical Laboratory Practice (GCLP).
  • Jim Lu, M.D., CEO and Medical Director for GoPath Diagnostics, said: “Our collaboration with Nucleai transforms our capabilities, enabling GoPath to deliver a seamlessly integrated lab workflow.